2018 - 2019 ISPE Board of Directors Installed

ISPE installed its 2018 – 2019 International Board of Directors at their 2018 ISPE Annual Meeting & Expo, revealing a slate of strategic leaders who represent a variety of pharmaceutical industry sectors. The Board is responsible for the governance and strategic direction of the Society.

The following pharmaceutical industry leaders have been elected to the 2018 – 2019 ISPE International Board of Directors:

Officers:

Chair

Vice Chair

Treasurer

Secretary

Past Chair

Re-Elected Director:

Christine Moore

Executive Director, Quality Systems & Compliance

Organon LLC

New Directors:

Vivianne Arencibia

Vice President, Global Quality Systems and Compliance

Moderna

Gunter Baumgartner

SVP Head of Global Engineering

Takeda Pharmaceuticals International AG

Caroline Rocks, CEng

Senior Program Manager

AbbVie, Inc.

Appointed Director:

Chris Chen, PhD

CEO

WuXi Biologics (Shanghai) Co., Ltd.

Continuing Board Members:

In addition to those named above, the following Directors were elected in 2017 to serve a two-year term and will continue their service on the Board:

Antonio C. Crincoli, PE

Vice President of Global Engineering

Catalent Pharma Solutions

SVP Head of Product Supply Fill & Finish Expansions

Novo Nordisk A/S

Vice President, Head of PMO Project Management

Celonic Ag

Alice Redmond, PhD

Chief Strategy Officer

CAI

Michael Rutherford

Interim President and CEO

ISPE

Young Professionals Representative (Ex Officio):

LeAnna M. Pearson

Associate Director Quality Compliance and Regulatory

CAI

Learn more about ISPE’s International Board of Directors.